Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Katukyadi Churna is a traditional Ayurvedic polyherbal formulation primarily used for the management of hepatobiliary and digestive disorders. Its lead ingredient is Katuki (*Picrorhiza kurroa*), which contains bioactive iridoid glycosides such as picroside I and II, known for their potent hepatoprotective, anti-inflammatory, and choleretic properties. In clinical evaluations, the formulation has shown efficacy in treating Non-Alcoholic Steatohepatitis (NASH) by significantly reducing liver stiffness (as measured by elastography), improving liver function tests (ALT, AST, bilirubin), and lowering BMI and triglycerides. It is typically administered as a fine powder (churna) taken orally with water.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on katukyadi churna.